Opinion|Videos|October 21, 2024

Implementing Photodynamic Therapy to Improve Patient Outcomes

Author(s)Anthony M. Rossi, MD, FAAD, FACMS

Key Takeaways

PDT has demonstrated efficacy in treating non-melanoma skin cancers, esophageal cancer, and certain lung cancers.
A patient with early-stage esophageal cancer achieved complete remission after undergoing PDT.
Increased PDT use can boost patient satisfaction by providing a non-invasive treatment with minimal side effects.
PDT can improve practice outcomes by reducing recovery times and hospital stays, leading to cost savings and better resource allocation.

SHOW MORE

Anthony M. Rossi, MD, highlights a successful case of photodynamic therapy (PDT), provides background on the patient’s outcome, and explains how increased use of PDT can enhance patient satisfaction and improve practice outcomes.

Episodes in this series

1 KOL is featured in this series.

EP. 1 What Is Red Light Therapy and Why Should It Be Used

1 KOL is featured in this series.

EP. 2 Red Light Therapy in Wound Care and Acne

1 KOL is featured in this series.

EP. 3 Looking to the Future of Red Light Therapy

EP. 4 Exploring Photodynamic Therapy

EP. 4 Exploring Photodynamic Therapy

EP. 5 Tips for Integrating Photodynamic Therapy in the Clinic

EP. 5 Tips for Integrating Photodynamic Therapy in the Clinic

EP. 6 Challenges and Successes in Photodynamic Therapy

EP. 6 Challenges and Successes in Photodynamic Therapy

EP. 7 Addressing Barriers to Photodynamic Therapy

EP. 7 Addressing Barriers to Photodynamic Therapy

EP. 8 Implementing Photodynamic Therapy to Improve Patient Outcomes

EP. 8 Implementing Photodynamic Therapy to Improve Patient Outcomes

EP. 9 The Continued Evolution of Photodynamic Therapy

EP. 9 The Continued Evolution of Photodynamic Therapy

Ted Lain, MD, MBA, FAAD, is featured in this series.

EP. 10 Combination Approach in Photodynamic Therapy

Ted Lain, MD, MBA, FAAD, is featured in this series.

EP. 11 Reviewing Benefits of Combination Therapy With Photodynamic Therapy

Ted Lain, MD, MBA, FAAD, is featured in this series.

EP. 12 How to Select the Best Photodynamic Therapy Approach

1 KOL is featured in this program

EP. 13 Understanding Patterns in Seasonality of Photodynamic Therapy

1 KOL is featured in this program

EP. 14 Making PDT Adjustments and Maintaining Patient Flow

1 KOL is featured in this program

EP. 15 Photodynamic Pearls and Best Practices

EP. 16 Enhancing Photodynamic Therapy With Red Light Applications, Patient Comfort, and Seasonal Trends

EP. 16 Enhancing Photodynamic Therapy With Red Light Applications, Patient Comfort, and Seasonal Trends

Video content above is prompted by the following:

Do you have a specific example to share of a successful use of PDT and background on that patient success?
How can the increased use of PDT impact patient satisfaction and practice outcomes?

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Latest CME

Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis

Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis

Tina Bhutani, MD, MAS, FAAD; Jason E. Hawkes MD, MS

Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis

Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis

Milan J. Anadkat, MD; Johann E. Gudjonsson MD, PhD; Robert G. Micheletti, MD

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

Paul G. Auwaerter, MD, MBA; Paul P. Doghramji, MD, FAAFP; Aruna Subramanian, MD

‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis

‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis

Raj Chovatiya, MD, PhD, MSCI, FAAD; Michael Rubio, PA-C, MMSc

Dermalorian™ Webinar: Shedding Light on Patient-Reported Outcomes to Assess Disease Severity in Patients With Atopic Dermatitis

Dermalorian™ Webinar: Shedding Light on Patient-Reported Outcomes to Assess Disease Severity in Patients With Atopic Dermatitis

Joseph Gorelick, MSN, FNP-C

Where Do Biologics Fit Into the Management of Moderate-to-Severe Atopic Dermatitis?

Where Do Biologics Fit Into the Management of Moderate-to-Severe Atopic Dermatitis?

Brad P. Glick, DO, MPH, FAAD

Expert Illustrations & Commentaries™: Exploring Novel Therapeutic Targets in Acne Management

Expert Illustrations & Commentaries™: Exploring Novel Therapeutic Targets in Acne Management

Hilary Baldwin; Neal Bhatia, MD

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Revolutionizing Atopic Dermatitis (RAD) Conference 2026

In-Person Event

Revolutionizing Atopic Dermatitis (RAD) Conference 2026

June 17-19, 2026

Clinical Consultations™: Providing Holistic Care for Complex Cases of Psoriasis with Cardiovascular Comorbidities

Clinical Consultations™: Providing Holistic Care for Complex Cases of Psoriasis with Cardiovascular Comorbidities

Brittany Weber MD, PhD, FACC, FAHA; Lourdes M. Perez-Chada MD, MMSc

Understanding Topical Steroid Withdrawal (TSW) in Patients With Atopic Dermatitis (AD)

Understanding Topical Steroid Withdrawal (TSW) in Patients With Atopic Dermatitis (AD)

Diego Ruiz Dasilva, MD, FAAD; Brad Glick, DO, MPH. FAAD; Peter Lio, MD

Assessing the Evidence for OX40-OX40L Axis Inhibition for the Treatment of Atopic Dermatitis

Assessing the Evidence for OX40-OX40L Axis Inhibition for the Treatment of Atopic Dermatitis

Johann Gudjonsson, MD, PhD; Christopher Bunick, MD, PhD

Navigating Safety Data with Janus Kinase (JAK) Inhibitors in Atopic Dermatitis (AD) Management

Navigating Safety Data with Janus Kinase (JAK) Inhibitors in Atopic Dermatitis (AD) Management

Andrew Alexis, MD, MPH; Leon Kircik, MD

Patient, Provider, and Caregiver Connection™: Addressing Patient Challenges With Holistic Approaches to Vitiligo Management

Patient, Provider, and Caregiver Connection™: Addressing Patient Challenges With Holistic Approaches to Vitiligo Management

Andrew F. Alexis, MD, MPH; Chesahna Kindred, MD, MBA, FAAD

Burst CME™: Optimizing Care for Patients with Psoriasis – Incorporating a Buy-and-Bill Model for Biologic Agents into Dermatological Practice

Burst CME™: Optimizing Care for Patients with Psoriasis – Incorporating a Buy-and-Bill Model for Biologic Agents into Dermatological Practice

Jerry Bagel, MD, MS

Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient

Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient

Douglas DiRuggiero, DMSc, MHS, PA-C; Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP

Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches

Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches

Hadar Lev-Tov, MD; Martina Porter, MD

Trending on Dermatology Times - Dermatology News and Clinical Insights

STRATA Excimer Laser and JAK Inhibitors Delivers Superior Vitiligo Repigmentation

Vitiligo Disease Duration Linked to Depression Severity

APG777 May Ease Burden on Patients With AD

Evaluating Dose-Dependent Skin Changes from Long-Term Isotretinoin Therapy, Including CHE

Tailoring Psoriasis Therapy for Adherence, Comorbidities, and Hard-to-Treat Areas

© 2025 MJH Life Sciences^®

All rights reserved.